[1] |
ZHAI Yu, YANG Jin.
Effects of dietary vitamin K on the stability of warfarin anticoagulation therapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 709-715.
|
[2] |
WANG Xiaqin, HE Fei, WANG Tong, HU Zhangle.
Admission Neutrophil-to-lymphocyte ratio predicts coronary lesion complexity and clinical risk in patients with unstable angina pectoris
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(3): 296-300.
|
[3] |
FAN Meijun, WANG Jinling, MA Kai, KONG Xiuling.
Treatment for 56 cases of recurrent oral ulcer associated with helicobacter pylori based on riple therapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(9): 1050-1055.
|
[4] |
WANG Jue,QIAO Qing, CHENG Maoliang, LI Wanchun, WANG Yipin, YING Wei.
Effects of Ginkgo biloba tablet on MPA, CD11b and MCP-1 levels in patients with unstable angina pectoris
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(12): 1421-1425.
|
[5] |
HUO Yong-jia.
Effects of fluvastatin on exercise-induced myocardial ischemia in patients with stable exertional angina pectoris and hypercholesterolemia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(2): 200-203.
|
[6] |
ZHOU Ping.
Study on the influence factors on the stability of cefuroxime, ceftriaxone and cefotaxime injections
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(7): 770-774.
|
[7] |
SHI Hai-xia, HUANG Ji-han, LI Qing-hai, BIAN Ka.
Effects of Quyuningxin pill to unstable angina pectoris efficacy and serum C-reactive protein
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(5): 582-585.
|
[8] |
LV Ying-hua, HE Ying-chun, YANG Juan, XU Ling, LIU Hong-xia, ZHENG Qing-shan.
Study of the symptoms scale for evaluating changes in patients with coronary angina pectoris and Qi-deficiency combined with stagnation of blood in traditional Chinese medicine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(7): 786-791.
|
[9] |
ZHANG Qiong, ZHANG Xiang-nong, TU Xiu-hua.
Clinical efficacy and safety of shexiang xintongning tablets in treatment of patients with coronary heart disease and angina pectoris
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(9): 1069-1072.
|
[10] |
XIANG Nan, HU You-Zhi, SHI Jie, ZHANG Feng, FENG De-Xun.
Efficacy and safety of xindakang capsules in treatment of patients with angina pectoris
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(9): 1033-1036.
|
[11] |
HUO Yong-Jia, CHENG Ying, CHENG Li.
Clinical evaluation of efficacy of simvastatin on exercise-induced myocardial ischemia in patients with stable exertional angina pectoris and hypercholesterolemia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(8): 929-931.
|
[12] |
HU You-Zhi, SHI Jie, XIANG Nan, ZHANG Feng, WANG Yan-Li, Feng DE-Xun, DENG A-Li.
Efficacy and safety of xuesetong pills in the treatment of patients with angina pectoris
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(10): 1168-1171.
|
[13] |
XING Ji-Ping, BAO Ju-Tai, LI Zhi-Tian, SUN Guo, ZHANG Rui-Hong, WANG Shuang-Min.
Clinical evaluation of antitoxin cachet for coxsackie B myocarditis in treatment ofPatients with viral myocarditis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(6): 701-703.
|
[14] |
CHEN Shao-Liang, DUAN Bao-Xiang, WU Xiang, ZHANG Xiao-Ling, YE Fei, HU Zuo-Ying.
Characteristics of myocardial blood flow distribution in patients with angina pectoris and normal coronary arteriograms
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2001, 6(2): 132-137.
|
[15] |
WANG An-Cai, CHA NG Bao-Hua, YANG Shan-Ying, NI Wei-Hua, YANG Hao, HUANG Jia-Sheng.
Effect of baoxinbaofilm on plasma endothel in and nitricoxide levels in patients with stable angina pectoris
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2000, 5(2): 145-146.
|